Incap Corporation: Incap increases its estimate for the 2019 result


Incap Corporation                                  
Stock Exchange Release, Inside information
13 September 2019 at 2.30 p.m. (EEST)                   

Incap increases its estimate for the 2019 result

Incap Corporation estimates that the Group’s full-year revenue and operating profit (EBIT) in 2019 will be clearly higher than in 2018. The previous guidance in the half-year financial report was that the revenue and operating profit (EBIT) in 2019 will be higher than in 2018. Both estimations assume that there are no major changes in currency exchange rates or component availability.

In 2018, the Group's revenue amounted to EUR 59.0 million and the operating profit (EBIT) was EUR 8.6 million. In January-June 2019, the Group's revenue amounted to EUR 37.2 million and the operating profit (EBIT) was EUR 5.7 million.

The guidance was revised due to the increased demand especially from existing customers. In addition Incap has managed to broaden its customer base.   

Incap Group’s Business Review for January-September 2019 will be published on 6 November 2019.


Further information:
Otto Pukk, President & CEO, tel. +372 508 0798

Nasdaq Helsinki Ltd.
Major media

Incap Corporation is an international contract manufacturer. Incap's customers are leading suppliers of high-technology equipment in their own business segments, and Incap increases their competitiveness as a strategic partner. Incap has operations in Finland, Estonia, India and China, and the company currently employs approximately 830 people. Incap's share is listed on the Nasdaq Helsinki Ltd. as from 1997. Additional information:

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Mandalay Resources Corporation Announces Financial Results for the Second Quarter of 202012.8.2020 23:45:02 CESTPress release

TORONTO, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND, OTCQB: MNDJF) today announced its financial results for the quarter ended June 30, 2020. The Company’s unaudited condensed and consolidated interim financial results for the quarter ended June 30, 2020, together with its Management’s Discussion and Analysis (“MD&A”) for the corresponding period, can be accessed under the Company’s profile on and on the Company’s website at All currency references in this press release are in U.S. dollars except as otherwise indicated. For the second quarter of 2020, the Company generated revenue of $42.3 million, adjusted EBITDA of $21.3 million, and adjusted net income of $7.6 million, or $0.08 income per share. Commenting on the results, Dominic Duffy, President and CEO of Mandalay, noted, “Mandalay’s strong second quarter financial performance was driven by another all-time record in quarterly ad

Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease12.8.2020 22:01:00 CESTPress release

-- Companies to jointly validate novel drug targets -- -- Scipher eligible for upfront, opt-in and milestone payments -- -- Galapagos to progress selected targets into drug discovery -- Mechelen, Belgium and Boston, USA; 12 August 2020 - Galapagos NV (Euronext & Nasdaq: GLPG) and Scipher Medicine (Scipher), a Boston based privately held precision medicine company focused on autoimmune diseases, today announce a collaboration to advance novel drug targets identified by Scipher for the treatment of inflammatory bowel disease (IBD). Scipher combines its proprietary Network Medicine Platform with molecular patient data and AI-based methods to identify novel targets and pathways in autoimmune diseases, including IBD. Scipher and Galapagos will jointly validate a suite of novel IBD targets discovered by Scipher after which Galapagos has the exclusive option to progress up to five targets into further drug discovery and development. Under the terms of the agreement, Scipher is eligible to rec

AND International Publishers NV (ticker: AND.AS) publishes its half year results and trading update12.8.2020 18:05:00 CESTPress release

Capelle aan den IJssel, the Netherlands, 12 August 2020: AND International Publishers NV (ticker: AND.AS) is pleased to share today its half year results and trading update TRADING UPDATE AND HALF YEAR 2020 RESULTS AND grows topline by 22% and reduces net loss by 19% in Covid-19 impacted economic environment. Covid-19 and the related measures taken to prevent the spread of the Corona virus have proved to be a significant challenge for the global economy. The AND team and our underlying business have shown resilience: revenue has increased by 22% compared to the same period in 2019. This is mainly due to our success in winning and delivering new service projects, and moderately growing our existing recurring business. The direct impact of the lockdown was felt most in the data sales segment, where it was difficult to connect with key decision makers and win new customers. OPERATIONAL HIGHLIGHTS AND STRATEGY UPDATE The year began with a good sales pipeline, but the anti-pandemic measures

Volta Finance Limited - Director/PDMR Shareholding12.8.2020 18:03:45 CESTPress release

12 August 2020 VOLTA FINANCE LIMITED (VTA / VTAS) Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons On 12 August 2020, Mr Paul Meader, Director and Chairman of the Board of the Company, transferred 4,495 shares in the Company to his wife, Sarah Kingwell. Following this transaction the total interests in the Company of Mr Meader (and his Closely Associated Persons) remain unchanged at 40,598 shares, representing 0.11% of the issued shares in the Company. The below notification, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, gives further details: 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Paul MeaderSarah Kingwell 2 Reason for the notification a) Position/status Director and Chairman PCA b) Initial notification /Amendment Initial Notification 3 Details of the issuer, emission allowance market participant, auction platform, auct

Volta Finance Limited : Net Asset Value as at 31 July 202012.8.2020 18:00:00 CESTPress release

Volta Finance Limited (VTA / VTAS) – July 2020 monthly report NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES ***** Guernsey, 12 August 2020 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for July. The full report is attached to this release and will be available on Volta’s website shortly ( PERFORMANCE and PORTFOLIO ACTIVITY In July the monthly performance, after considering the 11 cents per share dividend paid 29th of July, is negative at -1.2%. Despite a flat performance at the asset class level, USD weakness had a negative impact as USD depreciated against EUR by 4.6% during the month while, after adjusting for hedging, Volta has a USD exposure close to 45%. The monthly asset class performances** were, in local currency: -0.3% for Bank Balance Sheet transactions, +1.1% for CLO Equity tranches; -0.5% for CLO Debt; +5.9% for Cash Corporate Credit deals (this